ClinVar Miner

Submissions for variant NM_144997.7(FLCN):c.610_611delinsTA (p.Ala204Ter) (rs398124538)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Division of Genomic Diagnostics,The Children's Hospital of Philadelphia RCV000133394 SCV000298051 pathogenic Multiple fibrofolliculomas 2016-07-18 criteria provided, single submitter clinical testing
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000082640 SCV000114682 pathogenic not provided 2013-01-31 criteria provided, single submitter clinical testing
GeneReviews RCV000133394 SCV000188411 pathogenic Multiple fibrofolliculomas 2014-08-07 no assertion criteria provided literature only
Invitae RCV000133394 SCV000632880 pathogenic Multiple fibrofolliculomas 2017-02-02 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal at codon 204 (p.Ala204*) of the FLCN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FLCN are known to be pathogenic. This particular variant has been reported in the literature in many families and individuals affected with Birt-Hogg-Dubé syndrome (BHD) (PMID: 17611575, 18234728, 20522427, 25519458, 26603437, 27652079). This variant is also known as c.1065_1066delGCinsTA in the literature. An experimental study has shown that this sequence change impairs the stability of the FLCN protein in cell culture (PMID: 21538689). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.